Connect with us

Business

Johnson & Johnson COVID-19 vaccine under review by European Medicines Agency over blood clots – ABC News

Europe’s drug regulator says it is reviewing rare blood clots in four people in the United States who received Johnson & Johnson’s COVID-19 vaccine.

Published

on

Article feature image

Europes drug regulator says it is reviewing rare blood clots in four people in the United States who received Johnson & Johnsons COVID-19 vaccine.
Key points:

  • Johnson & Johnson said it was aware of the rare reports of blood clots, and was working with regulators to assess the data
  • The US Food and Drug Administration said it was aware of the reports, but they had “not found a causal relationship with vaccination”
  • It follows an investigation of blood clots reported by some people given the AstraZeneca…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

2 buy-rated blue chip ASX 200 shares for investors in May
Article feature image
2 high quality ASX shares for your retirement portfolio – The Motley Fool Australia